Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14010041
Abstract: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and is associated with a dismal median survival of 2–9 months. The fundamental limitations and ineffectiveness of current HCC treatments have led to the… read more here.
Keywords: cancer; carcinoma new; hepatocellular carcinoma; treatment ... See more keywords